Orchid Pharma Limited

NSE:ORCHPHARMA.NS

784.9 (INR) • At close May 8, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) INR.

202420232022202120202019201820172016201520142013201220112010200920082007200620052004
Omzet 8,190.6636,658.9845,595.5744,500.6044,838.0155,999.8056,829.8337,965.0418,594.99911,644.06612,984.66512,278.65917,923.23417,817.90313,434.53412,968.48913,009.6399,638.239,366.3067,223.3846,699.945
Kosten van de omzet 5,031.8334,012.5443,270.922,413.0232,240.1965,752.0013,731.6287,178.4417,507.08910,141.60311,699.2356,552.4439,086.59810,327.4378,395.4595,856.194,793.1813,536.3724,284.1093,331.2135,748.124
Brutowinst 3,158.832,646.442,324.6542,087.5812,597.819247.8043,098.205786.61,087.911,502.4631,285.435,726.2168,836.6367,490.4665,039.0757,112.2998,216.4586,101.8585,082.1973,892.171951.821
Brutowinstmarge 0.3860.3970.4150.4640.5370.0410.4540.0990.1270.1290.0990.4660.4930.420.3750.5480.6320.6330.5430.5390.142
Onderzoek- en ontwikkelingskosten 70.93763.62166.26348.097119.285139.618177.333376.014316.51401.037580.3320693.287259.9970000000
Algemene en administratieve kosten 84.26487.86588.986128.989239.875142.949173.039206.581122.8810224.4170386.5971,284.280003,336.0472,707.66300
Verkoop- en marketingkosten 238.563143.363222.617134.5592.042103.434220.963261.886277.3140370.1440632.597550.5790000000
Verkoop-, algemene en administratieve kosten 322.827231.228309.031263.507313.14246.383394.002468.467400.1951,396.8261,536.10201,019.1941,834.8590003,336.0472,707.66300
Overige kosten 02,095.6852,281.8862,285.2652,866.4333,238.7173,421.9184,040.23,450.975-59.805,972.0214,769.1583,242.898-2,081.9765,885.9635,110.803847.33845.9862,956.80896.284
Bedrijfskosten 2,422.1062,390.5342,657.1422,596.9013,298.8583,624.7183,993.2534,884.6814,167.681,797.8622,155.6535,972.0216,481.6395,337.754-2,081.9765,885.9635,110.8034,183.3773,553.6492,956.80896.284
Bedrijfsresultaat 784.691296.69-338.899-504.944-701.039-736.564-895.048-1,093.147-3,212.589-47.265-870.16-245.8052,626.5782,152.7117,121.0511,226.3363,105.6551,918.4811,528.548935.346855.537
Bedrijfsresultaat ratio 0.0960.045-0.061-0.112-0.145-0.123-0.131-0.137-0.374-0.004-0.067-0.020.1470.1210.530.0950.2390.1990.1630.1290.128
Totaal overige inkomsten en kosten netto 134.761255.779-230.088-447.5454.1211,430.643-3,094.582-4,344.612248.955-2,544.259-2,812.93-2,780.895-1,872.216-437.064-2,422.704-1,564.501-820.005-992.915-878.448-735.458-583.789
Inkomen voor belasting 919.452552.469-568.987-952.489-696.918694.079-3,989.63-5,437.759-2,963.634-2,591.524-3,683.09-3,026.7754.3621,715.6474,698.347-338.1652,285.65925.566650.1199.888271.748
Inkomen voor belasting ratio 0.1120.083-0.102-0.212-0.1440.116-0.584-0.683-0.345-0.223-0.284-0.2470.0420.0960.35-0.0260.1760.0960.0690.0280.041
Belastingkosten -31.19121.53535.2270-0.10-461.944-483.422-172.507-1,276.39-83.484-272.958-220.421153.7791,305.808151.734532.251140.07877.1-21.03319.5
Nettowinst 921.665463.183-19.512-1,165.3-1,310.701694.079-3,527.686-4,954.337-2,791.127-1,311.019-3,720.182-2,753.742974.7831,561.8683,392.539-489.8991,753.399785.488573220.921250.359
Nettowinstmarge 0.1130.07-0.003-0.259-0.2710.116-0.517-0.622-0.325-0.113-0.287-0.2240.0540.0880.253-0.0380.1350.0810.0610.0310.037
WPA (Winst Per Aandeel) 19.0611.35-0.48-28.55-14.757.8-39.65-55.69-32.07-3,905.89-11,509.89-39.0913.8422.1748.16-7.1426.9311.9510.274.535.15
Verwaterde WPA 19.0611.35-0.48-28.55-14.757.8-39.65-55.69-32.07-3,905.89-11,509.36-39.0913.6718.3238.21-5.4617.9110.759.434.30
EBITDA 1,419.1791,429.359635.819658.739523.9452,060.392359.979-559.5561,431.483,531.4221,481.0011,325.7714,051.484,218.218,670.0472,566.2614,112.4392,769.3742,386.7241,573.1761,455.627
EBITDA ratio 0.1730.2150.1140.1460.1080.3430.053-0.070.1670.3030.1140.1080.2260.2370.6450.1980.3160.2870.2550.2180.217